Es gab 50 kürzliche Insider-Transaktionen für Harpoon Therapeutics, Inc. (HARP), darunter 36 Käufe und 12 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $494.5M und die gesamten Insider-Verkäufe auf $2.38M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Merck & Co., Inc., Bailes Joseph S, Silvernail Lauren P. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — HARP
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-03-11 |
Merck & Co., Inc. |
10 Percent Owner |
Informierter Kauf |
21,397,205 |
$23.00 |
$492.14M |
1,000 |
| 2024-03-11 |
Bailes Joseph S |
Director |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Silvernail Lauren P |
Director |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Hunt Ronald |
10 Percent Owner |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Myers Scott Dunseth |
Director |
Aktienrückgabe |
4,600 |
$6.66 |
$30.62K |
- |
| 2024-03-11 |
Eastland Julia Marie |
President and CEO |
Aktienrückgabe |
40,759 |
$8.90 |
$362.76K |
- |
| 2024-03-11 |
Drachman Jonathan G |
Director |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Robbins Andrew R |
Director |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
Aktienrückgabe |
8,643 |
$6.97 |
$60.24K |
- |
| 2024-03-11 |
Bucher James B |
Chief Legal Officer |
Aktienrückgabe |
110,000 |
$11.30 |
$1.24M |
- |
| 2024-03-11 |
Walker Luke Nathaniel |
Chief Medical Officer |
Aktienrückgabe |
10,000 |
$8.90 |
$89K |
- |
| 2024-03-11 |
Chin Mark |
Director |
Aktienrückgabe |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
New Leaf Biopharma Opportunities Ii, L.p. |
10 Percent Owner |
Aktienrückgabe |
85,750 |
$5.83 |
$500.31K |
- |
| 2024-03-08 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
424 |
- |
- |
13,224 |
| 2024-03-08 |
Drachman Jonathan G |
Director |
RSU-Zuteilung |
415 |
- |
- |
5,415 |
| 2024-03-08 |
Chin Mark |
Director |
RSU-Zuteilung |
424 |
- |
- |
13,224 |
| 2024-01-07 |
Eastland Julia Marie |
President and CEO |
RSU-Zuteilung |
178,500 |
- |
- |
232,003 |
| 2024-01-07 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
RSU-Zuteilung |
15,000 |
- |
- |
18,362 |
| 2024-01-07 |
Walker Luke Nathaniel |
Chief Medical Officer |
RSU-Zuteilung |
115,000 |
- |
- |
135,000 |
| 2024-01-07 |
Merck & Co., Inc. |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
| 2024-01-01 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
1,072 |
- |
- |
12,801 |
| 2024-01-01 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
2,048 |
- |
- |
22,666 |
| 2024-01-01 |
Chin Mark |
Director |
RSU-Zuteilung |
1,072 |
- |
- |
12,801 |
| 2023-12-21 |
Bucher James B |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-21 |
Bucher James B |
Chief Legal Officer |
RSU-Zuteilung |
110,000 |
$11.30 |
$1.24M |
110,000 |
| 2023-11-27 |
Bailes Joseph S |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Silvernail Lauren P |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
5,000 |
- |
- |
11,729 |
| 2023-11-27 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
20,618 |
| 2023-11-27 |
Drachman Jonathan G |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Robbins Andrew R |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Chin Mark |
Director |
RSU-Zuteilung |
5,000 |
- |
- |
11,729 |
| 2023-11-26 |
Eastland Julia Marie |
President and CEO |
RSU-Zuteilung |
50,000 |
- |
- |
53,503 |
| 2023-11-26 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
RSU-Zuteilung |
2,000 |
- |
- |
3,362 |
| 2023-11-26 |
Walker Luke Nathaniel |
Chief Medical Officer |
RSU-Zuteilung |
20,000 |
- |
- |
20,000 |
| 2023-10-25 |
Hunt Ronald |
10 Percent Owner |
Informierter Kauf |
85,750 |
$5.83 |
$500.31K |
85,750 |
| 2023-10-25 |
New Leaf Biopharma Opportunities Ii, L.p. |
10 Percent Owner |
Informierter Kauf |
85,750 |
$5.83 |
$500.31K |
85,750 |
| 2023-10-01 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
3,035 |
- |
- |
6,729 |
| 2023-10-01 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
5,797 |
- |
- |
15,618 |
| 2023-10-01 |
Chin Mark |
Director |
RSU-Zuteilung |
3,035 |
- |
- |
6,729 |
| 2023-07-01 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
18,656 |
- |
- |
36,941 |
| 2023-07-01 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
35,634 |
- |
- |
98,215 |
| 2023-07-01 |
Chin Mark |
Director |
RSU-Zuteilung |
18,656 |
- |
- |
36,941 |
| 2023-06-22 |
Bailes Joseph S |
Director |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Silvernail Lauren P |
Director |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Hunt Ronald |
10 Percent Owner |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
46,000 |
$0.67 |
$30.62K |
46,000 |
| 2023-06-22 |
Drachman Jonathan G |
Director |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Robbins Andrew R |
Director |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Chin Mark |
Director |
RSU-Zuteilung |
23,000 |
$0.67 |
$15.31K |
23,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
